Zum Hauptinhalt springen
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Selection of stabilizing agents to provide effective penetration of gold nanoparticles into cells

  • EMAIL logo , , , , , , und
Veröffentlicht/Copyright: 12. September 2014
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Objective:

Gold nanorods are known to be promising agents for photothermal therapy. But the uptake of rod-shaped nanoparticles is lower than their spherical counterpart. It was therefore the objective of this study to select gold nanoparticles (GNPs)-stabilizing agents in order to provide effective penetration into cancer cells.

Materials and methods:

The work was carried out on human ovarian adenocarcinoma SKOV-3 cells. The gold nanorods used in this work had a plasmon resonance peak at 800 nm. The nanoparticles were stabilized by Pluronic® F-127 (PF127), chitosan or polyethylene glycol (PEG); the latter with 6000 Da and 40,000 Da molecular weight. Penetration and intracellular distribution of GNPs were investigated by transmission electron microscopy (TEM) and two-photon luminescence microscopy (2PLM) techniques.

Results:

By means of 2PLM and TEM, it could be shown that PF127 facilitates cellular uptake of GNPs very effectively. PF127-stabilized GNPs rapidly (by 1.5 h) penetrated the cell membrane and into the cytoplasm and cell nucleus. GNPs stabilized by chitosan were slowly internalized by the cells in smaller amount. GNPs stabilized by PEG with different molecular weights had difficulty to penetrate into the cells – GNPs were localized on the outer side of the cell membrane after short incubation, and single agglomerates were found in the cells after an extended incubation time.

Conclusion:

Nanoparticles stabilized with PF127 were the most effective nanoparticles to penetrate into the cells and were located in the cytoplasm and cell nuclei. Nanoparticles stabilized with chitosan were internalized into cells at a slower rate and in smaller amounts than those stabilized with PF127. Nanoparticles stabilized with PEG6000 Da and PEG40.000 Da were located mainly on cell membranes and could be found in the cytoplasm only after a longer incubation time.

Zusammenfassung

Ziel:

Gold-Nanostäbchen gelten als vielversprechend für den Einsatz in der photothermischen Therapie, jedoch ist die Aufnahme von stabförmigen Nanopartikeln geringer als die ihrer runden Gegenstücke. Ziel dieser Studie war es daher, geeignete Substanzen zu finden, die geeignet sind, um Gold-Nanopartikel zu stabilisieren und so ein wirksames Eindringen in Krebszellen zu gewährleisten.

Materialien und Methoden:

Die Studie wurde an humanen Eierstock-Adenokarzinomzellen, sogenannten SKOV-3-Zellen, durchgeführt. Es wurden Gold-Nanostäbchen verwendet, deren Maximum der Plasmonresonanz bei 800 nm lag. Die Nanopartikel wurden entweder mit Pluronic® F-127 (PF127), Chitosan oder Polyethylenglykol (PEG) mit einem Molekulargewicht von 6000 Da bzw. 40.000 Da stabilisiert. Die Penetration und intrazelluläre Verteilung der Gold-Nanopartikel wurden mittels Transmissionselektronenmikroskopie (TEM) und Zwei-Photonen-Lumineszenz-Mikroskopie (2PLM) untersucht.

Ergebnisse:

Die Untersuchungen mittels 2PLM und TEM zeigten, dass PF127 die zelluläre Aufnahme der Gold-Nanopartikel effektiv erleichtert. Die mit PF127 stabilisierten Nanopartikel drangen schnell (nach 1,5 h) in die Zellwand sowie ins Zytoplasma und den Zellkern ein. Die mit Chitosan stabilisierten Nanopartikel wurden von den Zellen langsamer und in geringerer Menge aufgenommen. Die Gold-Nanopartikel, die mit PEG6000 Da bzw. PEG40.000 Da stabilisiert wurden, hatten Schwierigkeiten in die Zellen einzudringen; nach kurzer Inkubation wurden Nanopartikel auf der Außenseite der Zellmembran lokalisiert, nach einer längeren Inkubationszeit einzelne Agglomerate in den Zellen gefunden.

Schlussfolgerung:

Mit PF127 stabilisierte Gold-Nanopartikel waren die wirksamsten Nanopartikel, um in die Zellen einzudringen und wurden im Zytoplasma und Zellkern lokalisiert. Nanopartikel, die mit Chitosan stabilisiert wurden, drangen mit einer geringeren Geschwindigkeit und in kleineren Mengen in die Zellen ein als die mit PF127 stabilisierten. Die mit PEG6000 Da und PEG40,000 Da stabilisierten Gold-Nanopartikel befanden sich hauptsächlich auf den Zellmembranen und konnten im Zytoplasma erst nach einer längeren Inkubationszeit festgestellt werden.


Corresponding author: Vadim V. Elagin, Institute of Biomedical Technologies, Nizhny Novgorod State Medical Academy, 603005 Minin Sq. 10/1, Nizhny Novgorod, Russia; and Department of Biology, Nizhny Novgorod State University, 603950 Gagarin Ave. 23, Nizhny Novgorod, Russia, e-mail:

References

[1] Visaria RK, Griffin RJ, Williams BW, Ebbini ES, Paciotti GF, Song CW, Bischof JC. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery. Mol Cancer Ther 2006;5(4):1014–20.10.1158/1535-7163.MCT-05-0381Suche in Google Scholar PubMed

[2] Chen YH, Tsai CY, Huang PY, Chang MY, Cheng PC, Chou CH, Chen DH, Wang CR, Shiau AL, Wu CL. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharm 2007;4(5):713–22.10.1021/mp060132kSuche in Google Scholar PubMed

[3] Stern JM, Stanfield J, Kabbani W, Hsieh JT, Cadeddu JA. Selective prostate cancer thermal ablation with laser activated gold nanoshells. J Urol 2008;179(2):748–53.10.1016/j.juro.2007.09.018Suche in Google Scholar PubMed

[4] von Maltzahn G, Park JH, Agrawal A, Bandaru NK, Das SK, Sailor MJ, Bhatia SN. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res 2009;69(9):3892–900.10.1158/0008-5472.CAN-08-4242Suche in Google Scholar PubMed PubMed Central

[5] Huang X, Peng X, Wang Y, Wang Y, Shin DM, El-Sayed MA, Nie S. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 2010;4(10):5887–96.10.1021/nn102055sSuche in Google Scholar PubMed PubMed Central

[6] Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett 2007;7(7):1929–34.10.1021/nl070610ySuche in Google Scholar PubMed

[7] Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H, Pushpanketh S, McDonald JF, El-Sayed MA. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett 2008;269(1):57–66.10.1016/j.canlet.2008.04.026Suche in Google Scholar PubMed PubMed Central

[8] Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B 2006;110(14):7238–48.10.1021/jp057170oSuche in Google Scholar PubMed

[9] Chithrani BD, Ghazani AA, Chan WC. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006;6(4):662–8.10.1021/nl052396oSuche in Google Scholar PubMed

[10] Kanaras AG, Bartczak D, Sanchez-Elsner T, Millar TM, Muskens OL. Gold nanoparticles in biomedical applications. Proc SPIE 2011;7909:79090J. doi: 10.1117/12.871602.10.1117/12.871602Suche in Google Scholar

[11] Escobar-Chávez JJ, López-Cervantes M, Naík A, Kalia YN, Quintanar-Guerrero D, Ganem-Quintanar A. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 2006;9(3):339–58.Suche in Google Scholar

[12] Manaspon C, Viravaidya-Pasuwat K, Pimpha N. Preparation of folate-conjugated pluronic F-127/chitosan core-shell nanoparticles encapsulating doxorubicin for breast cancer treatment. J Nanomater 2012(2012):593878. doi:10.1155/2012/593878.10.1155/2012/593878Suche in Google Scholar

[13] Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006;23(12):2709–28.10.1007/s11095-006-9104-4Suche in Google Scholar PubMed

[14] Artursson P, Lindmark T, Davis SS, Illum L. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 1994;11(9):1358–61.10.1023/A:1018967116988Suche in Google Scholar

[15] Sarmento B, das Neves J, editors. Chitosan-based systems for biopharmaceuticals: Delivery, targeting and polymer therapeutics. Chichester: John Wiley & Sons; 2012.10.1002/9781119962977Suche in Google Scholar

[16] Ahmad MB, Tay MY, Shameli K, Hussein MZ, Lim JJ. Green synthesis and characterization of silver/chitosan/polyethylene glycol nanocomposites without any reducing agent. Int J Mol Sci 2011;12(8):4872–84.10.3390/ijms12084872Suche in Google Scholar PubMed PubMed Central

[17] He RY, Su YD, Cho KC, Lin CY, Chang NS, Chang CH, Chen SJ. Surface plasmon-enhanced two-photon fluorescence microscopy for live cell membrane imaging. Opt Express 2009;17(8):5987–97.10.1364/OE.17.005987Suche in Google Scholar PubMed

[18] Durr NJ, Larson T, Smith DK, Korgel BA, Sokolov K, Ben-Yakar A. Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods. Nano Lett 2007;7(4):941–5.10.1021/nl062962vSuche in Google Scholar PubMed PubMed Central

[19] Peckys DB, de Jonge N. Visualizing gold nanoparticle uptake in live cells with liquid scanning transmission electron microscopy. Nano Lett 2011;11(4):1733–8.10.1021/nl200285rSuche in Google Scholar PubMed PubMed Central

[20] Freese C, Gibson MI, Klok HA, Unger RE, Kirkpatrick CJ. Size- and coating-dependent uptake of polymer-coated gold nanoparticles in primary human dermal microvascular endothelial cells. Biomacromolecules 2012;13(5):1533–43.10.1021/bm300248uSuche in Google Scholar PubMed

[21] Coulter JA, Jain S, Butterworth KT, Taggart LE, Dickson GR, McMahon SJ, Hyland WB, Muir MF, Trainor C, Hounsell AR, O’Sullivan JM, Schettino G, Currell FJ, Hirst DG, Prise KM. Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles. Int J Nanomedicine 2012;7:2673–85.10.2147/IJN.S31751Suche in Google Scholar PubMed PubMed Central

[22] Nikoobakht B, El-Sayed MA. Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method. Chem Mater 2003;15(10):1957–62.10.1021/cm020732lSuche in Google Scholar

[23] Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006;128(6):2115–20.10.1021/ja057254aSuche in Google Scholar PubMed

[24] Guan Z, Polavarapu L, Xu QH. Enhanced two-photon emission in coupled metal nanoparticles induced by conjugated polymers. Langmuir 2010;26(23):18020–3.10.1021/la103668kSuche in Google Scholar PubMed

[25] Popov VI, Davies HA, Rogachevsky VV, Patrushev IV, Errington ML, Gabbott PL, Bliss TV, Stewart MG. Remodelling of synaptic morphology but unchanged synaptic density during late phase long-term potentiation (LTP): a serial section electron micrograph study in the dentate gyrus in the anaesthetized rat. Neuroscience 2004;128(2):251–62.10.1016/j.neuroscience.2004.06.029Suche in Google Scholar PubMed

[26] Albanese A, Chan WC. Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano 2011;5(7):5478–89.10.1021/nn2007496Suche in Google Scholar PubMed

[27] Miyamoto D, Oishi M, Kojima K, Yoshimoto K, Nagasaki Y. Completely dispersible PEGylated gold nanoparticles under physiological conditions: modification of gold nanoparticles with precisely controlled PEG-b-polyamine. Langmuir 2008;24(9):5010–7.10.1021/la703813fSuche in Google Scholar PubMed

[28] Bhattarai SR, Bahadur RKC, Aryal S, Bhattarai N, Kim SY, Yi HK, Hwang PH, Kim HY. Hydrophobically modified chitosan/gold nanoparticles for DNA delivery. J Nanopart Res 2008;10(1):151–62.10.1007/s11051-007-9233-7Suche in Google Scholar

[29] Klapshina LG, Douglas WE, Grigoryev IS, Ladilina EY, Shirmanova MV, Mysyagin SA, Balalaeva IV, Zagaynova EV. Novel PEG-organized biocompatible fluorescent nanoparticles doped with an ytterbium cyanoporphyrazine complex for biophotonic applications. Chem Commun (Camb) 2010;46(44):8398–400.10.1039/c0cc02842hSuche in Google Scholar PubMed

[30] Rahme K, Oberdisse J, Schweins R, Gaillard C, Marty JD, Mingotaud C, Gauffre F. Pluronics-stabilized gold nanoparticles: investigation of the structure of the polymer-particle hybrid. Chemphyschem 2008;9(15):2230–6.10.1002/cphc.200800358Suche in Google Scholar PubMed

[31] Bhattarai SR, Kc RB, Kim SY, Sharma M, Khil MS, Hwang PH, Chung GH, Kim HY. N-hexanoyl chitosan stabilized magnetic nanoparticles: Implication for cellular labeling and magnetic resonance imaging. J Nanobiotechnology 2008;6:1.10.1186/1477-3155-6-1Suche in Google Scholar PubMed PubMed Central

[32] Alkilany AM, Murphy CJ. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J Nanopart Res 2010;12(7):2313–33.10.1007/s11051-010-9911-8Suche in Google Scholar

[33] Erukova VY, Krylova OO, Antonenko YN, Melik-Nubarov NS. Effect of ethylene oxide and propylene oxide block copolymers on the permeability of bilayer lipid membranes to small solutes including doxorubicin. Biochim Biophys Acta 2000;1468 (1–2):73–86.10.1016/S0005-2736(00)00244-3Suche in Google Scholar

[34] Rahme K, Gauffre F, Marty J-D, Payré B, Mingotaud C. A systematic study of the stabilization in water of gold nanoparticles by poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers. J Phys Chem C 2007;111(20):7273–9.10.1021/jp070274+Suche in Google Scholar

[35] Kumar GT, Prakash NJ, Laxmi N, Krishna TD. Biotechnology based drug delivery by pegylation method. JRAP 2011;2(1):95–102. http://www.ijrap.net/admin/php/uploads/368_pdf.pdf [Accessed on August 1, 2014].Suche in Google Scholar

[36] Chen HL, Hu QH, Liang WQ. Effect of Pluronic on cellular uptake of cationic liposomes-mediated antisense oligonucleotides. Pharmazie 2004;59(2):131–3.Suche in Google Scholar

[37] Li X, Chen D, Le C, Zhu C, Gan Y, Hovgaard L, Yang M. Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake. Int J Nanomedicine 2011;6:3151–62.Suche in Google Scholar

[38] Alakhova DY, Rapoport NY, Batrakova EV, Timoshin AA, Li S, Nicholls D, Alakhov VY, Kabanov AV. Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers. J Control Release 2010;142(1):89–100.10.1016/j.jconrel.2009.09.026Suche in Google Scholar PubMed PubMed Central

[39] Rapoport N, Marin A, Luo Y, Prestwich GD, Muniruzzaman MD. Intracellular uptake and trafficking of pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization. J Pharm Sci 2002;91(1):157–70.10.1002/jps.10006Suche in Google Scholar PubMed

[40] Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int J Pharm 2009;382(1–2):198–204.10.1016/j.ijpharm.2009.07.023Suche in Google Scholar PubMed

[41] Lee JY, Choi YS, Suh JS, Kwon YM, Yang VC, Lee SJ, Chung CP, Park YJ. Cell-penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy. Int J Cancer 2011;128(10):2470–80.10.1002/ijc.25578Suche in Google Scholar PubMed

[42] Lavertu M, Méthot S, Tran-Khanh N, Buschmann MD. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 2006;27(27):4815–24.10.1016/j.biomaterials.2006.04.029Suche in Google Scholar PubMed

[43] Armida, Malugin A, Ghandehari H. Cellular uptake and toxicity of gold nanoparticles in prostate cancer cells: a comparative study of rods and spheres. J Appl Toxicol 2010;30(3):212–7.Suche in Google Scholar

Received: 2014-5-29
Revised: 2014-7-28
Accepted: 2014-8-15
Published Online: 2014-9-12
Published in Print: 2014-11-1

©2014 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 23.4.2026 von https://www.degruyterbrill.com/document/doi/10.1515/plm-2014-0016/html?lang=de
Button zum nach oben scrollen